Usefulness of preoperative assay of arginase in pancreatic cancer patients;Przydatność przedoperacyjnego oznaczania arginazy u chorych na raka trzustki

Polski Merkuriusz Lekarski

Volumn 15, Issue 90, 2003, Pages 511-514

  Porembska, Zofia ^a   Ścibior, Dorota ^a   Lewandowska, Katarzyna ^b   Małkowski, Piotr ^b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b Katedra i Klinika Chirurgii Ogolnej   (Poland)

Author keywords

Arginase; Ca 19 9; Cancer of pancreas; CEA; Markers of cancerogenesis

Indexed keywords

ARGINASE; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; SERUM;

ADULT; AGED; ARGINASE; CA-19-9 ANTIGEN; CARRIER PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 1642557242     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chinard FP.: Photometric estimation of prolin and ornithine. J. Biol. Chem., 1952, 199, 91-95.
2. Faverog G. i wsp.: Ca 19-9 and carcinoembrionic antigen in pancreatic cancer diagnosis. Cancer, 1986, 57, 1576-86.
3. Forones N., Tanaka M.: CEA and Ca 19-9 as prognostic index in colorectal cancer. Hepato-Gastroenterol., 1999, 46, 905.
4. Gold P., Freedman S.O.: Determination of tumor specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med., 1965, 121, 439.
5. Grotowski M. i wsp.: Przydatność przedoperacyjnego oznaczania antygenów CEA i Ca 19-9 u chorych na raka jelita grubego. Pol. Merk. Lek., 2001, 66, 476.
6. Kokocińska D. i wsp.: Antygeny: Ca 19-9, karcinoembrionalny CEA, Ca 50 i ferrytyna w nowotworach przewodu pokarmowego. Pol. Przegl. Chir., 1993, 65, 237-43.
7. Kokocińska D.: Przydatność oznaczeṅ markerów nowotworowych w chirurgii układu pokarmowego. Chirurgia Pol., 1999, 12, 101-15.
8. Koprowski M., Steplowski K.: Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet., 1979, 5, 957-72.
9. Kusela P. i wsp.: Comparison of Ca 19-9 and carcinoembrionic antigen (CEA) levels in the serum of patients with colorectal disease. Br. J. Cancer, 1984, 49, 135.
10. Maglund C. i wsp.: Evaluation of Ca 19-9 as a serum tumor marker in pancreatic cancer. Br. J. Cancer, 1986, 53, 197-202.
11. Maglund C.: Tumor marker antigen Ca 125 in pancreatic cancer: a comparison with Ca 19-9 and CEA. Br. J. Cancer, 1986, 54, 897-901.
12. Magnani J.L. i wsp.: Identification of the gastrointestinal and pancreatic cancer associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res., 1983, 43, 5489-92.
13. Malesci A. i wsp.: Determination of Ca 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. Gastroenterology, 1987, 92, 60-7.
14. Paganuzzi M. i wsp.: Ca 19-9 and Ca 50 in benign and malignant pancreatic and biliary diseases. Cancer, 1988, 61, 2100-08.
15. Porembska Z. i wsp.: Arginase isoforms in human colorectal cancer. Clin. Chim. Acta, 2001, 305, 157-65.
16. Porembska Z. i wsp.: Arginaza jako marker procesu nowotworowego. I. Monitorowanie chorych po resekcji raka jelita grubego. Pol. Merk. Lek., 2002, 76, 284-85.
17. Porembska Z. i wsp.: Serum arginase activity in postsurgical monitoring of patients with colorectal carcinoma. Cancer, 2002, 94, 2930-35.
18. Sato T. i wsp.: Serological studies on CEA, Ca 19-9, STn and SLX in colorectal cancer. Hepato-Gastroenterol., 1999, 46, 914.
19. Steinberg W.M. i wsp.: Comparison of the sensitivity and specificity of the Ca 19-9 and carcinoembrionic antigen assays in detecting cancer of the pancreas. Gastroenterology, 1986, 90, 343-9.
20. Tatsuta M. i wsp.: Values of Ca 19-9 in the serum, pure pancreatic juice and a aspirated pancreatic material in the diagnosis of malignant pancreatic tumor. Cancer, 1985, 56, 2669-73.
21. Wójcik Z.: Ostre zapalenie trzustki. Pol. Merk. Lek., 2001, 55, 38.